<DOC>
	<DOCNO>NCT02413593</DOCNO>
	<brief_summary>This study evaluate antiviral efficacy , safety , tolerability ledipasvir/sofosbuvir ( LDV/SOF ) fix dose combination ( FDC ) plus ribavirin ( RBV ) treatment-naive adult chronic genotype 3 hepatitis C virus ( HCV ) infection .</brief_summary>
	<brief_title>Safety Efficacy Ledipasvir/Sofosbuvir ( LDV/SOF ) Fixed Dose Combination Tablet With Ribavirin 12 Weeks Treatment-naive Adults With Chronic HCV Genotype 3 Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<mesh_term>Ledipasvir</mesh_term>
	<mesh_term>Ledipasvir , sofosbuvir drug combination</mesh_term>
	<criteria>Key Chronic genotype 3 HCV infection HCV treatmentnaive HCV RNA &gt; 10,000 IU/mL screen Absence cirrhosis compensate cirrhosis Screening laboratory value within define threshold Use two effective contraception method female childbearing potential sexually active male Key Pregnant nurse female male pregnant female partner Coinfection HIV hepatitis B virus ( HBV ) Current prior history clinical hepatic decompensation Chronic use systemic immunosuppressive agent History clinically significant illness medical disorder may interfere individual 's treatment , assessment , compliance protocol Note : Other protocol define Inclusion/Exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>HCV genotype 3 ( GT-3 )</keyword>
	<keyword>HCV</keyword>
	<keyword>Sustained Virologic Response</keyword>
	<keyword>Direct Acting Antiviral</keyword>
	<keyword>GS-7977</keyword>
	<keyword>GS-5885</keyword>
	<keyword>Ribavirin</keyword>
	<keyword>Sofosbuvir</keyword>
	<keyword>Ledipasvir</keyword>
	<keyword>Hepatitis C</keyword>
	<keyword>Hepatitis C , Chronic</keyword>
</DOC>